Poseida Therapeutics Inc

NASDAQ:PSTX   3:59:51 PM EDT
5.05
-0.21 (-3.99%)
Products

Poseida Therapeutics Announces FDA Clearance Of Investigational New Drug Application For P-MUC1C-ALLO1

Published: 12/20/2021 13:28 GMT
Poseida Therapeutics Inc (PSTX) - Poseida Therapeutics Announces FDA Clearance of Investigational New Drug Application for P-muc1c-allo1, a Fully Allogeneic Car-t Targeting Multiple Solid Tumors.